Thank you!
We will contact you shortly
popular questions
Have a Question?
1. Where are Cubed’s clinical and research operations based?
Our R&D and GMP-grade manufacturing facility is located in Montreal, Canada. We also operate and are developing partnerships for clinical trial sites and therapeutic dosing centers under the Voyage Therapeutics brand.
2. Is Cubed Biotech licensed to work with psilocybin and other controlled substances?
Yes. Cubed Biotech operates under a Health Canada Controlled Substances Dealer’s Licence, allowing us to legally possess, produce, and sell psilocybin and related compounds for research and clinical use.
3. What does Cubed Biotech do?
Cubed Biotech develops and manufactures natural and synthetic psychedelic compounds for mental health treatment. We specialize in high-purity psilocybin extraction (CB-001 “Tigrina”), hybrid novel psychedelics (CB-002 “Ocelot”), and direct-to-patient therapeutic models under the Voyage Therapeutics brand.
4. Can I invest in Cubed Biotech or partner with your team?
We welcome interest from accredited investors, researchers, and clinical partners. Please contact us to explore investment opportunities, clinical collaborations, or distribution partnerships.
3. How is Cubed Biotech different from other psychedelic companies?
Our edge lies in our vertically integrated model—from proprietary natural psilocybin isolation to next-gen hybrid drug development and patient care delivery. We’re also one of the few companies in North America with active IP in both classic and novel psychedelic manufacturing.
Feel Free to Reach Out
Fill in the form below, and I’ll personally reply to you.